In the second part of our exclusive interview with GSK Consumer Healthcare's EMEA Head Filippo Lanzi, we find out more about GSK’s new mission-oriented strategy, for example how its household European OTC brands like Dr Best and Alvedon are already going green. Widening access to medicines via Rx-to-OTC switch is also still a priority, Lanzi says, as well as exciting new trends in the region’s wellness market such as CBD.
Since becoming the largest OTC company in the world through its joint venture with Pfizer, GSK Consumer Healthcare is on a mission to make the post-COVID world a better place.
GSK has set itself the ambitious target of becoming carbon-neutral across all its operations by 2030, with the enlarged Consumer Healthcare business contributing to this goal through delivery of its own targets
“It’s quite likely [consumer wearable manufacturers] are changing the sensitivity and specificity based on consumer feedback, but not for medical reasons,” said Dipak Kotecha, a University of Birmingham professor of cardiology. Often, self-reported performance evidence from manufacturers is “low quality and biased.”
At a recent plenary session the European Parliament adopted a resolution calling on the European Commission to “conduct a new and comprehensive assessment” of the impact of the revised Urban Wastewater Treatment Directive on the pharmaceutical sector.
Germany’s Federal Institute for Risk Assessment says that there is "no evidence that people with androgenetic alopecia have special dietary needs or a special nutrient requirement.”
AESGP, MedTech Europe and other associations representing medtech companies including manufacturers of self-care devices call for such products to be included in European Commission proposals for “zero-for-zero” trade in industrial goods between Europe and the US.
AESGP, MedTech Europe and other associations representing medtech companies including manufacturers of self-care devices call for such products to be included in European Commission proposals for “zero-for-zero” trade in industrial goods between Europe and the US.
Just under half of Austrian pharmacists surveyed by Elpato Medien are “convinced that the OTC business will ensure the survival of their pharmacy.”
An application for melatonin as an OTC medicine is on the agenda for the next German switch committee meeting, despite the hormone being widely available in food supplements. Acyclovir as a buccal tablet and second-generation antihistamine rupatadine are also up for discussion.
